Hiroaki Akamatsu, Kazuhiro Negoro, Ryota Ueda, Keita Nakaguchi, Yuhei Harutani, Eri Takase, Katsuyuki Furuta, Yusuke Murakami, Eriko Murakami, Atsushi Hayata, Ke Wan, Toshio Shimokawa, Kuninobu Kanai, Nobuyuki Yamamoto. "A phase 2 study of CBDCA + PEM + pembrolizumab in elderly (≥75 yrs) patients with advanced non-Sq, NSCLC.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e20616